News

Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium

SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new …

Continue Reading

SpeeDx and Serosep sign UK and Ireland distribution agreement

SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will …

Continue Reading

SpeeDx receives FDA listing for Mycoplasma genitalium product

SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale …

Continue Reading

Updated guidelines for M. genitalium recommend resistance testing

The Australian STI management guidelines have been updated and now suggest when testing for Mycoplasma genitalium that inclusion of macrolide …

Continue Reading

TGA approval for SpeeDx PlexPCR® VHS | HSV-1&2, VZV & TP |

SpeeDx Multiplexed VZV, Herpes, Syphilis Assay is now fully registered as an IVD in the Australian market. The single-well test …

Continue Reading

New test developed for virulent STI

You may have never heard of it, but Mycoplasma genitalium – MG for short – is one of the most …

Continue Reading

Mycoplasma genitalium is thought to affect about 400,000 Australians…

…but many people have never heard of it. The bacterium can cause painful urination, itching and bleeding in the rectum, …

Continue Reading

Australian-made test makes doctor’s and patient’s life “a whole lot easier”

Mycoplasma genitalium is a little-known sexually transmitted infection affecting up to two per cent of the population. A new test …

Continue Reading

Aussie ‘Nobel’ spotlights SpeeDx war on superbug

Cicada Innovations, a “super incubator”, and headquarters for the SpeeDx office, manufacturing and production facilities, have created an event to …

Continue Reading

SpeeDx Pty. Ltd. establishes US-based operation

SpeeDx Pty. Ltd. announced the incorporation of a US-based subsidiary company, SpeeDx Inc. The US base will support current clinical …

Continue Reading